A rare non-synonymous c.102C>G SNP in the IFNB1 gene might be a risk factor for cerebral malaria in Indian populations

Infection, Genetics and Evolution

Volumn 14, Issue 1, 2013, Pages 369-374

  Jha, Aditya Nath ^a   Singh, Vipin Kumar ^a   Singh, Rajender ^b   Pati, Sudhanshu S ^c   Patra, Pradeep K ^d   Singh, Lalji ^a,e,f   Thangaraj, Kumarasamy ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

^c ISPAT GENERAL HOSPITAL   (India)

^d Pt Jawaharlal Nehru Memorial Medical College   (India)

^e BANARAS HINDU UNIVERSITY   (India)

^f Genome Foundation   (India)

Author keywords

Cerebral malaria; Cytokine; Interferon beta1; Malaria; Resistance; Susceptibility

Indexed keywords

BETA1 INTERFERON;

3' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; BRAIN MALARIA; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; IFNB1 GENE; INDIA; INDIAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PATHOGENESIS; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ALLELES; AMINO ACID SEQUENCE; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GEOGRAPHY, MEDICAL; HUMANS; INDIA; INTERFERON-BETA; MALARIA, CEREBRAL; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEQUENCE ALIGNMENT; YOUNG ADULT;

EID: 84873470485     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2012.12.029     Document Type: Article

References (22)

1. Adzhubei I.A., Schmidt S., Peshkin L., Ramensky V.E., Gerasimova A., Bork P., Kondrashov A.S., Sunyaev S.R. A method and server for predicting damaging missense mutations. Nat. Methods 2010, 7:248-249.
2. Beasley T.M., Schumacker R.E. Multiple regression approach to analyzing contingency tables: post hoc and planned comparison procedures. J. Exp. Educ. 1995, 64:79-93.
3. Belardelli F., Gresser I. The neglected role of type I interferon in the T-cell response: implications for its clinical use. Immunol. Today 1996, 17:369-372.
4. Chang K.H., Stevenson M.M. Malarial anaemia: mechanisms and implications of insufficient erythropoiesis during blood-stage malaria. Int. J. Parasitol. 2004, 34:1501-1516.
5. Driss A., Hibbert J.M., Wilson N.O., Iqbal S.A., Adamkiewicz T.V., Stiles J.K. Genetic polymorphisms linked to susceptibility to malaria. Malar. J. 2011, 10:271.
6. Durbin J.E., Fernandez-Sesma A., Lee C.K., Rao T.D., Frey A.B., Moran T.M., Vukmanovic S., Garcia-Sastre A., Levy D.E. Type I IFN modulates innate and specific antiviral immunity. J. Immunol. 2000, 164:4220-4228.
7. Eid N.A., Hussein A.A., Elzein A.M., Mohamed H.S., Rockett K.A., Kwiatkowski D.P., Ibrahim M.E. Candidate malaria susceptibility/protective SNPs in hospital and population-based studies: the effect of sub-structuring. Malar. J. 2010, 9:119.
8. Excoffier L., Laval G., Schneider S. Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol. Bioinform. Online 2005, 1:47-50.
9. Fell A.H., Currier J., Good M.F. Inhibition of Plasmodium falciparum growth in vitro by CD4+ and CD8+ T cells from non-exposed donors. Parasite Immunol. 1994, 16:579-586.
10. Goujon M., McWilliam H., Li W., Valentin F., Squizzato S., Paern J., Lopez R. A new bioinformatics analysis tools framework at EMBL-EBI. Nucleic Acids Res. 2010, 38:W695-699.
11. Gowda N.M., Wu X., Gowda D.C. TLR9 and MyD88 are crucial for the development of protective immunity to malaria. J. Immunol. 2012, 188:5073-5085.
12. Hill A.V. The immunogenetics of resistance to malaria. Proc. Assoc. Am. Physicians 1999, 111:272-277.
13. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., Thompson J.D., Gibson T.J., Higgins D.G. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23:2947-2948.
14. McGuire W., Knight J.C., Hill A.V., Allsopp C.E., Greenwood B.M., Kwiatkowski D. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J. Infect. Dis. 1999, 179:287-290.
15. Morrell C.N., Srivastava K., Swaim A., Lee M.T., Chen J., Nagineni C., Hooks J.J., Detrick B. Beta interferon suppresses the development of experimental cerebral malaria. Infect. Immun. 2011, 79:1750-1758.
16. Othoro C., Lal A.A., Nahlen B., Koech D., Orago A.S., Udhayakumar V. A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J. Infect. Dis. 1999, 179:279-282.
17. Stevenson M.M., Riley E.M. Innate immunity to malaria. Nat. Rev. Immunol. 2004, 4:169-180.
18. Thangaraj K., Joshi M.B., Reddy A.G., Gupta N.J., Chakravarty B., Singh L. CAG repeat expansion in the androgen receptor gene is not associated with male infertility in Indian populations. J. Androl. 2002, 23:815-818.
19. Tishkoff S.A., Varkonyi R., Cahinhinan N., Abbes S., Argyropoulos G., Destro-Bisol G., Drousiotou A., Dangerfield B., Lefranc G., Loiselet J., Piro A., Stoneking M., Tagarelli A., Tagarelli G., Touma E.H., Williams S.M., Clark A.G. Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Science 2001, 293:455-462.
20. van der Heyde H.C., Nolan J., Combes V., Gramaglia I., Grau G.E. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol. 2006, 22:503-508.
21. Vigario A.M., Belnoue E., Gruner A.C., Mauduit M., Kayibanda M., Deschemin J.C., Marussig M., Snounou G., Mazier D., Gresser I., Renia L. Recombinant human IFN-alpha inhibits cerebral malaria and reduces parasite burden in mice. J. Immunol. 2007, 178:6416-6425.
22. Waterhouse A.M., Procter J.B., Martin D.M., Clamp M., Barton G.J. Jalview version 2-a multiple sequence alignment editor and analysis workbench. Bioinformatics 2009, 25:1189-1191.